European-Wide Study Confirms Benefits of D-Penicillamine and Trientine for Wilson Disease, European Association for the Study of the Liver Reveals

Published: Mar 31, 2011

EurekAlert! -- Results from the first ever European-wide retrospective analysis presented today at the International Liver CongressTM have shown both D-penicillamine and trientine continue to be effective treatments, providing positive survival rates in patients with Wilson disease free from a liver transplant.

Back to news